Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
36.66
-1.10 (-2.91%)
At close: Mar 3, 2026, 4:00 PM EST
36.70
+0.04 (0.10%)
After-hours: Mar 3, 2026, 7:59 PM EST
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Sep 30, 2025 | 20.78B | 192.12M |
| Jun 30, 2025 | 22.25B | 332.68M |
| Mar 31, 2025 | 21.31B | 84.75M |
| Dec 31, 2024 | 20.19B | 98.03M |
| Sep 30, 2024 | 18.61B | 104.52M |
| Jun 30, 2024 | 17.54B | 79.69M |
| Mar 31, 2024 | 16.87B | 432.46M |
| Dec 31, 2023 | 15.75B | 466.61M |
| Sep 30, 2023 | 14.32B | 366.68M |
| Jun 30, 2023 | 12.97B | 656.67M |
| Mar 31, 2023 | 11.89B | 868.08M |
| Dec 31, 2022 | 10.66B | 1.17B |
| Sep 30, 2022 | 9.85B | 1.44B |
| Jun 30, 2022 | 9.04B | 1.46B |
| Mar 31, 2022 | 8.45B | 1.48B |
| Dec 31, 2021 | 7.83B | 1.44B |
| Sep 30, 2021 | 7.40B | 1.49B |
| Jun 30, 2021 | 6.87B | 1.62B |
| Mar 31, 2021 | 6.76B | 1.59B |
| Dec 31, 2020 | 6.92B | 1.64B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.